Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis

Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis

5
(555)
Write Review
More
$ 39.99
Add to Cart
In stock
Description

Integrating the transcriptome and proteome reveals two prognostic biomarkers for breast cancer, particularly for the estrogen receptor positive subset.

IJMS, Free Full-Text

Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes

Frontiers Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery

Integrating SWATH-MS Proteomics and Transcriptome Analysis Identifies CHI3L1 as a Plasma Biomarker for Early Gastric Cancer: Molecular Therapy - Oncolytics

Full article: Identification of significant genes and therapeutic agents for breast cancer by integrated genomics

Frontiers Integrated Transcriptome and Pathway Analyses Revealed Multiple Activated Pathways in Breast Cancer

Revolutionary Cancer Research Breakthroughs

Identification of potential diagnostic and prognostic biomarkers for breast cancer based on gene expression omnibus

Proteomes, Free Full-Text

Frontiers Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery

PDF) Survival analysis in breast cancer using proteomic data from four independent datasets

Proteomes, Free Full-Text

Proteomics and its applications in breast cancer.

Frontiers Integrative Analysis of Membrane Proteome and MicroRNA Reveals Novel Lung Cancer Metastasis Biomarkers

Identification of blood protein biomarkers for breast cancer staging by integrative transcriptome and proteome analyses - ScienceDirect